0001179110-18-010754.txt : 20180822 0001179110-18-010754.hdr.sgml : 20180822 20180822102959 ACCESSION NUMBER: 0001179110-18-010754 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180820 FILED AS OF DATE: 20180822 DATE AS OF CHANGE: 20180822 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Taylor Beth CENTRAL INDEX KEY: 0001522046 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35050 FILM NUMBER: 181031696 MAIL ADDRESS: STREET 1: 3000 KENT AVENUE STREET 2: SUITE A1-100 CITY: WEST LAFAYETTE STATE: IN ZIP: 47906 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENDOCYTE INC CENTRAL INDEX KEY: 0001235007 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3000 KENT AVE STE A1-100 CITY: WEST LAFAYETTE STATE: IN ZIP: 47906 BUSINESS PHONE: 7654637175 MAIL ADDRESS: STREET 1: 3000 KENT AVE STE A1-100 CITY: WEST LAFAYETTE STATE: IN ZIP: 47906 4 1 edgar.xml FORM 4 - X0306 4 2018-08-20 0 0001235007 ENDOCYTE INC ECYT 0001522046 Taylor Beth 3000 KENT AVE, STE A1-100 WEST LAFAYETTE IN 47906 0 1 0 0 VP Finance & Chief Acctg Offcr Common Stock 2018-08-20 4 S 0 285 18.2001 D 71255 D Represents the sale of 285 shares in a single transaction, at a price per share of $18.2001. The 285 shares were sold to cover taxes, commissions and fees associated with the August 18, 2018 settlement of 938 restricted stock units in the form of Company common stock on a one-for-one basis. The shares were sold by Merrill Lynch pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934 adopted by the reporting person on July 30, 2018. /s/ Beth A. Taylor 2018-08-22